Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone

Summary

This study is being conducted to compare the safety and effectiveness of the investigational medication LdT (telbivudine) used in combination with adefovir dipivoxil (a drug currently approved by the Food and Drug Administration \[FDA\] for the treatment of hepatitis B virus \[HBV\]) versus adefovir dipivoxil used alone. The results for patients taking the combination therapy will be compared to the results for patients taking adefovir alone.

Timeline

Start

2007-01

Primary completion

2008-08

Completion

—

Outcome

Outcome not reported

Stopped: “The study was not completed as planned and was terminated early with agreement from the European Medicines Agency (EMEA)”

Drugs

Indications